Simon is new FDA anti-inflammatory division director
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Lee Simon, MD, will start Nov. 19 as director of Division of Anti-Inflammatory, Analgesic and Ophthalmic Drug Products, replacing Acting Director Jonca Bull, MD. Simon, an associate professor of medicine at Harvard Medical School, was a principal investigator and lead author of Celecoxib Long-term Arthritis Safety Study. He has served as a consultant to Lilly, Forest, Aventis and Pharmacia/Searle